2XS-24233-68912
2 vaccinations
5 coded responses
22 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 371 / TN
- Registered
- 2021-04-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-23
Registered in v-safe
-
2021-04-23
Dose 1 — Pfizer-BioNTech
- 2021-04-23
-
2021-04-24
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Swelling · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-25
-
2021-04-26
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy — Feeling: Good · Site: Swelling · Muscle or body achesFree text: Swollen lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-27
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy — Feeling: GoodFree text: Lymph nodes still slightly swollenMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-28
Survey response — days 1–6 daily, dose 1MedDRA: Arthralgia, Pain in extremity — Feeling: GoodFree text: Slight arm / shoulder painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-29
- 2021-05-02
- 2021-05-09
-
2021-05-14
Dose 2 — Pfizer-BioNTech
- 2021-05-14
-
2021-05-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness · Headache, Fatigue or tirednessAdult check-in
-
2021-05-16
Survey response — days 1–6 daily, dose 2MedDRA: Nausea — Feeling: Good · Site: Pain · Headache, Fatigue or tirednessFree text: NauseaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-17
- 2021-05-18
- 2021-05-20
- 2021-05-23
- 2021-05-28
- 2021-06-04
- 2021-06-11
-
2021-06-18
Survey response — day 35, dose 2MedDRA: Tachycardia — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: TachycardiaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-18
Report sent to call center — day 35, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-22
- 2021-06-25
- 2021-11-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-23 | Pfizer-BioNTech | |
| 2 | 2021-05-14 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-06-18 | Unsuccessful |
Free text
Release 8 — days 1–6 daily, dose 1
Systemic reaction (other): Swollen lymph nodes
Systemic reaction (other): Lymph nodes still slightly swollen
Systemic reaction (other): Slight arm / shoulder pain
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Nausea
Release 9 — day 35, dose 2
Symptoms: Tachycardia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Tachycardia | ✓ | ✓ | ✓ |
| SRO | Arthralgia | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Nausea | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release